Filing Details

Accession Number:
0001104659-24-025684
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-20 19:52:18
Reporting Period:
2024-02-20
Accepted Time:
2024-02-20 19:52:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1425205 Iovance Biotherapeutics Inc. IOVA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1210317 A Merrill Mcpeak C/O Iovance Biotherapeutics, Inc.
825 Industrial Road, 4Th Floor
San Carlos CA 94070
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-20 250,000 $9.15 320,150 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 248,633 Indirect By Trust
Footnotes
  1. These shares are held by a family trust for which the reporting person is a trustee.
  2. Such shares purchased pursuant to Issuer's underwritten offering, which priced on 02/20/2024.
  3. Such number does not include 103,159 deferred restricted stock units, which are vested but not yet issued.
  4. Consists of 30,150 shares held in Keogh retirement account plus 40,000 shares as a result of exercised stock options plus 250,000 shares acquired in this offering.